Enterprise Value

174.7M

Cash

277.9M

Avg Qtr Burn

-11.87M

Short % of Float

40.42%

Insider Ownership

7.00%

Institutional Own.

85.97%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date